VJHemOnc is committed to improving our service to you

EBMT 2019 | Regulatory and commercialization challenges with CAR T-cell therapy

VJHemOnc is committed to improving our service to you

Bruce Levine

Bruce Levine, PhD, from the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, discusses the challenges regarding regulatory and commercialization of CAR T-cell therapy. Dr Levine was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter